CYCLOOXYGENASE INHIBITION, PLATELET-FUNCTION, AND METABOLITE FORMATION DURING CHRONIC SULFINPYRAZONE DOSING

被引:43
作者
PEDERSEN, AK [1 ]
FITZGERALD, GA [1 ]
机构
[1] VANDERBILT UNIV,MED CTR,SCH MED,DIV CLIN PHARMACOL,NASHVILLE,TN 37232
关键词
D O I
10.1038/clpt.1985.8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:36 / 42
页数:7
相关论文
共 37 条
[1]  
ALI A, 1977, J LAB CLIN MED, V89, P869
[2]  
[Anonymous], 1976, J Chronic Dis, V29, P625
[3]  
[Anonymous], 1980, CIRCULATION, V62, P449
[4]   PHARMACOKINETICS OF SINGLE DOSES OF SULPHINPYRAZONE AND ITS MAJOR METABOLITES IN PLASMA AND URINE [J].
BRADBROOK, ID ;
JOHN, VA ;
MORRISON, PJ ;
ROGERS, HJ ;
SPECTOR, RG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (02) :177-185
[5]  
BREDDIN K, 1979, THROMB HAEMOSTASIS, V41, P225
[6]   PROLONGED EFFECT OF SULFINPYRAZONE ON COLLAGEN-INDUCED PLATELET-AGGREGATION INVIVO [J].
BUCHANAN, MR ;
ROSENFELD, J ;
HIRSH, J .
THROMBOSIS RESEARCH, 1978, 13 (05) :883-892
[7]   A RANDOMIZED CONTROLLED TRIAL OF ACETYL SALICYLIC ACID IN THE SECONDARY PREVENTION OF MORTALITY FROM MYOCARDIAL INFARCTION [J].
ELWOOD, PC ;
COCHRANE, AL ;
BURR, ML ;
SWEETNAM, PM ;
WILLIAMS, G ;
WELSBY, E ;
HUGHES, SJ ;
RENTON, R .
BRITISH MEDICAL JOURNAL, 1974, 1 (5905) :436-440
[8]  
ELWOOD PC, 1979, LANCET, V2, P1313
[9]   QUANTITATIVE ANALYSIS OF TWO DINOR URINARY METABOLITES OF PROSTAGLANDIN I2 [J].
FALARDEAU, P ;
OATES, JA ;
BRASH, AR .
ANALYTICAL BIOCHEMISTRY, 1981, 115 (02) :359-367
[10]   SELECTIVE AND NONSELECTIVE INHIBITION OF THROMBOXANE FORMATION [J].
FITZGERALD, GA ;
OATES, JA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (05) :633-640